Caribou Biosciences, Inc. (CRBU)
1.65
-0.11
(-6.25%)
USD |
NASDAQ |
Aug 26, 16:00
1.66
+0.01
(+0.61%)
After-Hours: 04:17
Caribou Biosciences Shareholders Equity (Quarterly) : 98.10M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.10M |
| March 31, 2026 | 102.02M |
| December 31, 2025 | 122.18M |
| September 30, 2025 | 141.84M |
| June 30, 2025 | 166.13M |
| March 31, 2025 | 217.22M |
| December 31, 2024 | 252.95M |
| September 30, 2024 | 281.20M |
| June 30, 2024 | 310.46M |
| March 31, 2024 | 343.29M |
| December 31, 2023 | 368.40M |
| September 30, 2023 | 398.27M |
| Date | Value |
|---|---|
| June 30, 2023 | 269.46M |
| March 31, 2023 | 278.27M |
| December 31, 2022 | 300.87M |
| September 30, 2022 | 324.11M |
| June 30, 2022 | 347.89M |
| March 31, 2022 | 371.80M |
| December 31, 2021 | 387.82M |
| September 30, 2021 | 404.40M |
| June 30, 2021 | -47.69M |
| March 31, 2021 | -35.69M |
| December 31, 2020 | -23.44M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 727.71M |
| Vir Biotechnology, Inc. | 982.49M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.77M |
| Total Liabilities (Quarterly) | 44.67M |
| Debt to Equity Ratio | 0.2717 |
| Current Ratio | 6.487 |
| Net Debt Paydown Yield | -0.05% |